These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. Poon IO, Lal L, Brown EN, Braun UK. J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786 [Abstract] [Full Text] [Related]
4. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series. Schultz KT, Bungard TJ. Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606 [Abstract] [Full Text] [Related]
6. What to do when warfarin therapy goes too far. Prasad S, Wootten MR, Kulinski N, Chapman SA. J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771 [Abstract] [Full Text] [Related]
7. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry. Subherwal S, Peterson ED, Chen AY, Roe MT, Washam JB, Gage BF, Bach RG, Bhatt DL, Wiviott SD, Lopes RD, Alexander KP, Wang TY. Circulation; 2012 Mar 20; 125(11):1414-23. PubMed ID: 22319105 [Abstract] [Full Text] [Related]
8. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study. Crowther MA, Garcia D, Ageno W, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Schulman S, Kovacs M, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Thromb Haemost; 2010 Jul 20; 104(1):118-21. PubMed ID: 20458438 [Abstract] [Full Text] [Related]
9. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Yasaka M, Sakata T, Naritomi H, Minematsu K. Thromb Res; 2005 Jul 20; 115(6):455-9. PubMed ID: 15792675 [Abstract] [Full Text] [Related]
10. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Gunther KE, Conway G, Leibach L, Crowther MA. Thromb Res; 2004 Jul 20; 113(3-4):205-9. PubMed ID: 15140584 [Abstract] [Full Text] [Related]
16. Bleeding risks and response to therapy in patients with INR higher than 9. Pagano MB, Chandler WL. Am J Clin Pathol; 2012 Oct 20; 138(4):546-50. PubMed ID: 23010709 [Abstract] [Full Text] [Related]
17. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves. Yiu KH, Siu CW, Jim MH, Tse HF, Fan K, Chau MC, Chow WH. Am J Cardiol; 2006 Feb 01; 97(3):409-11. PubMed ID: 16442406 [Abstract] [Full Text] [Related]
20. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics. White RH, McKittrick T, Takakuwa J, Callahan C, McDonell M, Fihn S. Arch Intern Med; 1996 Jun 10; 156(11):1197-201. PubMed ID: 8639014 [Abstract] [Full Text] [Related] Page: [Next] [New Search]